These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 27890434
1. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Zhang JJ, Chen JT, Hua L, Yao KH, Wang CY. Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434 [Abstract] [Full Text] [Related]
2. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ. Cancer Res; 2011 Jun 01; 71(11):4028-39. PubMed ID: 21512140 [Abstract] [Full Text] [Related]
3. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Huang B, Huang M, Li Q. Pathol Res Pract; 2018 Dec 01; 214(12):1980-1986. PubMed ID: 30274685 [Abstract] [Full Text] [Related]
4. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H, Li B, Yang J. Biomed Pharmacother; 2018 Nov 01; 107():754-762. PubMed ID: 30142536 [Abstract] [Full Text] [Related]
5. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR. J Hepatol; 2014 Mar 01; 60(3):590-8. PubMed ID: 24211739 [Abstract] [Full Text] [Related]
6. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. Yang F, Lv LZ, Cai QC, Jiang Y. World J Gastroenterol; 2015 Dec 21; 21(47):13268-76. PubMed ID: 26715809 [Abstract] [Full Text] [Related]
7. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. Xia H, Ooi LL, Hui KM. PLoS One; 2012 Dec 21; 7(9):e44206. PubMed ID: 22962603 [Abstract] [Full Text] [Related]
8. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. Song H, Yu Z, Sun X, Feng J, Yu Q, Khan H, Zhu X, Huang L, Li M, Mok MTS, Cheng ASL, Gao Y, Feng H. EBioMedicine; 2018 Sep 21; 35():155-166. PubMed ID: 30150059 [Abstract] [Full Text] [Related]
9. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation. Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY. Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263 [Abstract] [Full Text] [Related]
10. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma. Chen Q, Zheng PS, Yang WT. Oncotarget; 2016 Jun 14; 7(24):36115-36129. PubMed ID: 27092879 [Abstract] [Full Text] [Related]
11. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A. Wang K, Jiang X, Jiang Y, Liu J, Du Y, Zhang Z, Li Y, Zhao X, Li J, Zhang R. J Exp Clin Cancer Res; 2023 Nov 27; 42(1):320. PubMed ID: 38008711 [Abstract] [Full Text] [Related]
12. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, Guan XY, Zeng MS, Xie D. Carcinogenesis; 2016 Jun 27; 37(6):557-566. PubMed ID: 27207647 [Abstract] [Full Text] [Related]
13. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis. Chen S, Pu J, Bai J, Yin Y, Wu K, Wang J, Shuai X, Gao J, Tao K, Wang G, Li H. J Exp Clin Cancer Res; 2018 Jan 09; 37(1):3. PubMed ID: 29316949 [Abstract] [Full Text] [Related]
14. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Cao F, Yin LX. Exp Mol Pathol; 2019 Feb 09; 106():34-43. PubMed ID: 30539797 [Abstract] [Full Text] [Related]
16. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J. FEBS J; 2013 Sep 09; 280(18):4531-8. PubMed ID: 23815091 [Abstract] [Full Text] [Related]
17. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway. Lu C, Jia S, Zhao S, Shao X. Cancer Biomark; 2019 Sep 09; 25(1):115-126. PubMed ID: 31006667 [Abstract] [Full Text] [Related]
19. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10. Cheng X, Wu C, Xu H, Zou R, Li T, Ye S. Aging (Albany NY); 2024 Feb 15; 16(4):3716-3733. PubMed ID: 38364252 [Abstract] [Full Text] [Related]
20. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination. Wen J, Xiong K, Aili A, Wang H, Zhu Y, Yu Z, Yao X, Jiang P, Xue L, Wang J. Theranostics; 2020 Feb 15; 10(12):5322-5340. PubMed ID: 32373215 [Abstract] [Full Text] [Related] Page: [Next] [New Search]